The spread of Burkholderia cepacia among cystic fibrosis (CF) patients in the UK prompted an investigation into whether an epidemic strain was responsible. A total of 366 B. cepacia isolates from 178 CF patients in 17 centres was examined by ribotyping and pulsed-field gel electrophoresis (PFGE). Associations were also sought between antibiotic resistance and strain type. More than 50 ribotype patterns were found but one, termed ribotype 1, was identified from 68 patients in eight centres. One centre had a single patient with this type while, in others, most or all patients harboured this organism. Small clusters of apparent cross-colonisation within centres were also evident for some other ribotypes. PFGE confirmed that ribotype 1 isolates were genetically similar. Ribotype 1 isolates were not markedly more resistant to antimicrobial agents than were other isolates, and the MICs of individual antibiotics were no more tightly clustered for ribotype 1 isolates than for others. Most isolates were resistant to ciprofloxacin, amikacin, gentamicin, tobramycin, carbenicillin, cefuroxime, cefotaxime, imipenem, biapenem, chloramphenicol, tetracycline, trimethoprim and sulphamethoxazole, but 2 77% were susceptible to ceftazidime, piperacillin, piperacillidtazobactam and meropenem. We conclude that numerous strains of B. cepacia 'colonise CF patients in the UK and Ireland but that one epidemic strain has spread in at least eight centres.
Introduction
Burkholderia (Pseudomonas) cepacia [ 11 is a pathogen of onions, in which it produces a 'sour and slippery skin' [2] . The species is also an occasional cause of hospital-acquired infection, for example, of bacteraemia in immunocompromised patients who received contaminated infbion fluids [3] . Since 1984, B. cepacia has been recognised as an infective agent in cystic fibrosis (CF) patients. Frequencies of isolation in some North American clinics rose from 10% of patients in the mid-1970s to nearly 40% 10 years later, almost certainly reflecting the spread of an epidemic strain [4, 5] . Systematic surveys of the prevalence of B. cepacia have not been undertaken nationally in the UK but a limited study reported that c. 7% of patients attending a regional CF centre harboured the organism [6] .
There is concern among CF patients and health-care workers about the risk of acquisition and transmission of B. cepacia [7] . Recent reports describe exchange of the organism among patients attending the same hospital clinic [8, 9] and, most disturbing of all, between CF patients at social gatherings [lo, 111. More generally, however, the extent of national spread of epidemic strains beyond the CF centres of Edinburgh and Manchester [lo] is unknown. Similarly, it is not known whether some strain types of the organism are associated with CF or, indeed, whether B. cepacia isolates from CF patients have unusual antibiotic resistances or virulence.
The present study describes the results of the typing of B. cepacia isolates from patients attending 17 CF centres in the UK and the Republic of Ireland. Tfling was performed hierarchically, with ribotyping [12] as the primary means of strain division and with genome macro-restriction analysis by pulsed-field gel electrophoresis (PFGE) [13] as a secondary technique, to discriminate within ribotypes. Antibiotic susceptibility tests also were performed and the results were examined for associations between strain types and resistances.
Materials and methods

Bacterial isolates
The collection of B. cepacia isolates comprised 366 organisms from 178 CF and two non-CF patients in 16 centres in the UK and one in the Republic of Ireland (Table 1) . Four further CF isolates from Denmark and eight from the USA were also tested; these were kindly provided by Drs N. Hoiby and T. Stull in Copenhagen and Philadelphia, respectively.
Isolates had been identified as B. cepacia by the forwarding laboratories by standard tests. Confirmatory tests were performed as necessary and included oxidative metabolism of glucose, and formation of acid from mannitol, ethanol, dulcitol, lactose and rhamnose in an ammonium salts-based medium [14] . Fifteen isolates failed to utilise glucose or any other sugar but grew well on B. cepacia selective medium and had other characteristics consistent with the species such as cytochrome oxidase production and failure to hydrolyse arginine.
Ribotyping
Chromosomal DNA was extracted from Nutrient Agar (Unipath) cultures by the method of Pitcher et al. [15] . DNA (5 pg) was digested with 20 units of restriction endonuclease Eco RI (Gibco BRL, Uxbridge, Middlesex), used according to the supplier's instructions. Restriction fragments were separated by electrophoresis in agarose 0.8% gels, then transferred to nylon filters under vacuum and hybridised with a cDNA probe to Escherichia coli (16s + 23s) rRNA, as described previously [ 161. Biotinylated Hind111 digests of lambda phage DNA (Gibco BRL) were included on the gels as mol. wt standards.
Pulsed-jield gel electrophoresis
The general protocol of Grothues et al. [17] was followed. Briefly, isolates were grown overnight on nutrient agar and then suspended in 1 ml of SE buffer (75 mM NaCl, 25 mM EDTA, pH 7.5) to a turbidity of 25-29 in an ATB 1550 densitometer (bioMkrieux, Basingstoke). The cell suspension (500 pl) was mixed with an equal volume of low-gelling agarose 2%, and blocks of uniform size were prepared. These were twice treated at 56°C overnight with lysis buffer (N-lauroyl sarcosinate 1%, 0.5 M EDTA, pH 9.5) containing proteinase K 500 pg/ml. After three washes with TE buffer (10 mM Tris, 10 mM EDTA, pH 7.5), the blocks were stored at 4°C in the same buffer. The DNA was then digested with the restriction enzymes XbaI or SpeI, used according to the supplier's instructions (Gibco BRL).
PFGE was performed in agarose 1.2% gels in a contour clamped homogeneous electric field apparatus (CHEF DR 11, BioRad, Heme1 Hempstead, Herts) for 35 h, with start-and end-pulse times of 5 s and 35 s, respectively. A concatamer ladder of lambda phage DNA was used as a size marker. Gels were stained with ethidium bromide for 1 h at room temperature, de-stained by shaking in distilled water, and photographed under UV transillumination.
Analysis of banding profiles
The presence and absence of bands in the ribotyping or CHEF gel lanes were scored as 1 or 0, respectively, and a pair-wise comparison of similarity for each isolate was made within a single electrophoretic run, by the Dice coefficient [18] with the aid of the computer program MVSP (Kovach Computing Services, Pentraeth, Anglesey).
Susceptibility tests
Isolates were grown for 48 h at 30°C in 10-ml volumes of nutrient broth and then diluted to c. 3 X lo7 cfidml. A multipoint inoculator was used to deliver 0.3-pl volumes of the dilutions to IsoSensitest Agar (Unipath) plates containing doubling dilutions of antimicrobial agents, thus giving inocula of c. lo4 cfidspot. The agents tested were: amikacin (Bristol-Myers Squibb, Hounslow, Middlesex); biapenem, piperacillin and piperacillin plus tazobactam (Lederle, Gosport, Hants); carbenicillin (SmithKline Beecham, Brockham Park, Surrey); cefotaxime and gentamicin (Roussel, Uxbridge, Middlesex); ceftazidime and cefuroxime (Glaxo, Greenford, Middlesex); chloramphenicol, sulphamethoxazole, tetracycline and trimethoprim (Sigma); ciprofloxacin (Bayer, Newbury, Berks); imipenem (Merck, Sharp and Dohme, Hoddesdon, Herts); meropenem (Zeneca, Macclesfield, Cheshire) and tobramycin (Eli Lilly, Basingstoke, Hants). Co-trimoxazole was tested as a 5:l ratio of sulphamethoxazole: trimethoprim. Plates containing either or both of the latter agents were supplemented with lysed horse blood 5% vlv.
Pseudomonas aeruginosa NCTC 10662 was included on all plates as a control. Results were read after incubation for 48 h at 30"C, and minimum inhibitory concentrations (MICs) were taken as the lowest drug concentrations required to prevent growth completely. When MICs for multiple isolates from the same patient were compared, differences of four-fold or greater (i.e., two doubling dilutions) were taken as significant, smaller differences were discounted.
Results
Ribotype patterns
Isolates of B. cepacia were received from 178 CF and two non-CF patients in 17 centres (Table 1) . Several ribotype patterns were evident among the isolates, each being characterised by four to eight rDNA fragments with molecular sizes between 1.5 and > 23 kb. The spectrum of differences in hybridisation patterns varied from major, with few bands in common, to single-band differences. The reproducibility of band positions between different blots corresponded to ? 0.5 kb for fragments < 9.0 kb to 2 2 kb for larger fragments.
More than 50 ribotype patterns were apparent but, because of the inter-run variation, it was not possible to assign a definitive type number to each of these. Nevertheless, one profile, termed ribotype 1, was widespread. This ribotype was characterised by the presence of seven constant bands accompanied or not by a further band of c. 5.8 kb ( Fig. 1 ) and was seen in all the asaccharolytic isolates (n = 15) as well as many typical, saccharolytic organisms. The pattern was identified in isolates from 68 patients in eight centres ( Table 1) . The proportion of patients with ribotype 1 isolates ranged from one of six in centre A through 13 or 16 in centre F, to all of six in centre Q. Only one episode of spread of ribotype 1 between centres (centres F and D) by patient transfer was documented. Ribotype 1 was not found among the Irish, Danish or North American CF isolates.
There was great heterogeneity among the isolates that were not of ribotype 1 (Table 1 ) and many patients harboured unique types. Nevertheless, small clusters of apparent cross-colonisation were identified. For example, six rDNA profiles were found among the nine . . . isolates from nine patients in centre B; five of these were unique to single patients but the sixth was shared by four patients. Clusters of apparent cross-colonisation between small numbers of patients were also evident in centre J, where nine different ribotypes, apart from ribotype 1, were identified in 26 or 47 patients and only three of these types were unique to individual patients. B. cepacia was found in seven sibling groups in four centres and, in each of these cases, the members of the pair or group harboured isolates of identical ribotype (Table 2) . Among non-siblings, 24 incidents of cross-colonisation were identified involving two-to-19 patients and a series of 20 isolates from a single patient over 13 months were indistinguishable from each other. Infection with strains of two different ribotypes was found in only 11 patients in five centres.
fewer bands, corresponding to Dice coefficients of > 90%.
Only four PFGE patterns, differing by three bands or fewer, could be distinguished among all ribotype 1 isolates throughout the UK, and one of these patterns was exclusively associated with the 15 asaccharolytic isolates from two centres. Autodegradation of chromosomal DNA was rare but, when it occurred (Fig. 2,  lane 7) , no DNA bands were visible after electrophoresis.
Homogeneity of ribotype 1
A variety of DNA macro-restriction profiles was revealed by PFGE for isolates of different ribotypes but those of ribotype 1 from different centres gave closely related profiles. This is illustrated in Fig. 2 which shows that the profiles of nine isolates from eight patients (lanes 1-6, and 8-10), including two sibling pairs (2 and 3, 4 and 5), differed by three or
Susceptibility tests
Susceptibility tests were performed on 102 ribotype 1 and 167 other isolates and the MICs found are shown as box plots in Fig. 3 . This mode of display is valid in the present study as all the MIC distributions were unimodal [19, 20] . The MIC5Os of most antimicrobial agents for the ribotype 1 isolates were one doubling dilution higher than for isolates of other ribotypes. MIC10, MIC25, MIC75 and MIC90 values also were 1 2 3 4 5 6 7 8 9 10
raised for the ribotype 1 isolates, and the MIC5Os of piperacillidtazobactam, trimethoprim and co-trimoxazole were 4-8-fold higher for these isolates than for those of other ribotypes. Nevertheless, there was substantial overlap between the MICs for ribotype 1 isolates and those for other ribotypes with all the antimicrobial agents. Moreover, and critically, the MICs of individual antimicrobial agents for ribotype 1 isolates were no more tightly clustered than were those for the isolates of diverse ribotypes. MIC ranges and MIC5Os for asaccharolytic and saccharolytic ribotype 1 isolates were very similar.
Among the 269 isolates for which MICs were determined, 153 were from patients (n = 56) who contributed more than one isolate. Fifty-three patients yielding multiple isolates had organisms of a single ribotype and only three had isolates of more than one ribotype. Normally multiple isolates of the same 2 3 4 5 6 -6 7 8 ribotype from the same patient would be excluded from antibiotic resistance analysis, but this was not in susceptibility Profile (Fig-4 and resistant to a range of p-lactams than was the other of the same ribotype and PFGE profile, and had similar resistance to other agents. In others, exemplified by patient 2 in the same table, the MICs of structurally diverse antimicrobial agents were variously raised or lowered between two isolates of the same type from the same patient, without any apparent consistency.
Discussion
The question as to whether B. Number of antimicrobial agents with significant susceptibility differences among isolates from individual patients two methods together suggest that their interpretation is best achieved if they are considered in a hierarchical fashion with ribotyping forming the primary division of the species. Isolates of the same ribotyping can then be subdivided by PFGE to provide a definitive strain profile.
The present study aimed to identi@ the types of B. cepacia prevalent among British and Irish CF patients to determine whether particular strains predominated, and whether the inter-regional spread of a strain first demonstrated by Govan et al.
[lo] had extended to other centres. At least 50 different ribotypes were identified among the 366 isolates studied from the 180 patients, but variation between gels in the precise distances migrated by DNA fragments precluded allocation of ribotype numbers. Nevertheless, a common ribotype pattern differing by a single band between isolates was evident and was termed ribotype 1 to distinguish it from other patterns. were ribotype 1 and gave PFGE profiles highly similar to saccharolytic isolates of the same ribotype suggests that they are most likely variants of the latter.
Simpson et al. [25] described CF isolates which, by their biochemical characteristics and fatty acid content, more closely resembled B. gladioli than B. cepacia. These gave weak or negative reactions in maltose and lactose oxidation tests but they were not termed asaccharolytic. It is not certain that the asaccharolytic isolates examined here were B. cepacia or B. gladioli, but a plausible view is that the asaccharolytic strains are variants lacking a pivotal enzyme in glycolysis. Unlike Simpson et al. [25] substantial differences in antibiotic susceptibility between saccharolytic B. cepacia and asaccharolytic strains were not found.
Lack of information means that it was not possible to relate the clinical condition of patients to the presence or absence of the ribotype 1 organism, but it was clear from discussions with the responsible physicians that the clinical presentation of carriers varied from asymptomatic to severe respiratory infection. Thus, the ribotype 1 strain is not overly virulent for CF patients but does seem to be highly transmissible between patients and centres, having been found in nearly one-third of the present patients. This finding confirms the view of Govan et al.
[lo] that despite the fact that many Edinburgh patients were colonised with this strain and had raised antibody levels to the strain, prognostic statements could not be made as the index case of their outbreak remained alive while some others died.
The factors that influence the acquisition and persistence of a strain of B. cepacia by patients are unknown but adhesive ability, cell-wall structures, and production of virulence factors may be significant Simple point mutations might also explain some accumulation of resistance, for example, the differences in resistances to p-lactams between the two isolates from patient 1 ( Table 3) ; but seems unlikely as a source of the more diverse changes between the two isolates from patient 2.
No great optimism can be raised about the anti-B. cepacia activity of any antimicrobial agent tested. Over 58% of the isolates, whether of ribotype 1 or not, were resistant to each of the following agents at the 'high' breakpoints advocated by the British Society for Antimicrobial Chemotherapy (BSAC) 
